Posted in Clinical Data AstraZeneca lung drug gets ‘surprise’ win in COPD trials March 27, 2026 BioPharma Dive The treatment, tozorakimab, succeeded where other similar therapies failed and could help a broader group of COPD patients than Dupixent. Clinical DataRespiratoryRead full story